Prospective - trials in set-up or submitted for funding

PACMEL

A randomised phase 2 study of paclitaxel with or without GSK1120212 in advanced wt BRAF melanoma

DEBIOC

A Phase I dose-escalating and safety study of AZD8931 in combination with Oxaliplatin and Capecitabine chemotherapy in patients with Oesophago-gastric adenocarcinoma